Grace Science Grace Science is a company researching and developing therapeutics to treat NGLY1 deficiency. | ![]() MyMeds&Me MyMeds&Me is a SaaS provider of web-based adverse event and product capture solutions for life sciences. | Nextbiotics Nextbiotics is a company developing antibiotic alternatives for antibiotic-resistant infections. | ![]() Satellos Bioscience Satellos Bioscience is a biotechnology company developing medicines to treat degenerative muscle diseases. | ![]() CeleCor Therapeutics CeleCor Therapeutics is a company that provides a solution supporting the treatment of serious heart attacks. | |
Founding Date | Founding Date 2017 | Founding Date 2011 | Founding Date 2017 | Founding Date 2018 | Founding Date N/A |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Menlo Park, US HQ | Locations London, GB HQ Kingswood, GB | Locations Oakland, US HQ | Locations Toronto, CA HQ | Locations Del Mar, US HQ |
Employees | Employees 156% decrease | Employees 16 | Employees 3 | Employees 244% increase | Employees 5 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 959.6k (over 10 years ago) | Latest funding round $ 750k (over 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 1.3m | Total funding raised $ 750k | Total funding raised N/A | Total funding raised N/A |
MyMeds&Me is a SaaS provider of web-based adverse event and product capture solutions for life sciences.
View companyNextbiotics is a company developing antibiotic alternatives for antibiotic-resistant infections.
View companySatellos Bioscience is a biotechnology company developing medicines to treat degenerative muscle diseases.
View companyCeleCor Therapeutics is a company that provides a solution supporting the treatment of serious heart attacks.
View company